1. Is aging linear or does it follow a step function? A good & simple question on Quora that surprised even Aubrey de Grey. If you are a bioinformatician out there – looking for a new pet project – go pull together some data & try to plot it! Let me know if you have something.… Continue reading Three links in Aging, Regenerative Medicine & Healthy Lifespan Extension: 8 December 2013
Take a look at the FDA Application Approvals 2000-2008 visualization (created by user mktlgcs) over at IBM’s Many Eyes to get an aerial view on the US. pharmaceutical industry.
Philip Campbell, the open editor-in-chief of Nature was asked by John Brockman under the cover of the 2008 Edge Annual Question: WHAT HAVE YOU CHANGED YOUR MIND ABOUT? WHY? Campbell writes in his thoughtful answer: “I’ve changed my mind about the use of enhancement drugs by healthy people. A year ago, if asked, I’d have… Continue reading Nature Editor-in-Chief’s changed mind on enhancement drugs for healthy people
Linda Powers is the managing director and co-founder of Toucan Capital Corp, a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments (the fund markets itself as the The Leading US Investor in Stem Cells and Regenerative Medicine). Out of here insights and facts presented on the… Continue reading SENS3: The stem cell marketplace by Linda Powers, Tucan Capital (slides)
The Coalition to Extend Life launched today an online petition to U.S. Congress and President in order to make the technological possibility of Indefinite Life Extension a national priority and public policy goal of the United States. They ask the power people to create the 4 main conditions that will make it possible. 1. a… Continue reading Unlimited Life Extension Petition to U.S. Congress and President: a good address?
Finally a journalist at Wired, Brandon Keim thought it’s time to check out some facts and formulate real arguments in the embryonic stem cell funding debate instead of boondoggling. He has collected good historical examples of long-term funding in drug research, which then saved many lives, like Taxol, and has enumerated fields of promising science,… Continue reading Real arguments not just echo chambering in embryonic stem cell funding debate
Our first answerer to the 6 questions is Reason, who is the main driving force of the biggest and most established life extension site, Fight Aging! (Technorati Rank) and The Longevity Meme, continuously from 2001. 1. What is the story of your life extension commitment? I don’t like the idea of decaying, suffering and dying.… Continue reading Blogterview with Fight Aging!’s Reason: answers to life extension questions
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework